You are here
Clinical Trials: Urological Disease
Each Clinical Trial will open in a new browser window or tab.
Conditions: Type 2 Diabetes Mellitus; Chronic Kidney Disease
Interventions: Drug: Canagliflozin; Drug: Placebo
Sponsors: George Washington University; Janssen Scientific Affairs, LLC
Recruiting - verified September 2016
Interventions: Drug: Canagliflozin; Drug: Placebo
Sponsors: George Washington University; Janssen Scientific Affairs, LLC
Recruiting - verified September 2016
Condition: Hemolytic Uremic Syndrome
Intervention: Biological: Extra blood draw samples
Sponsor: Assistance Publique Hopitaux De Marseille
Recruiting - verified September 2016
Intervention: Biological: Extra blood draw samples
Sponsor: Assistance Publique Hopitaux De Marseille
Recruiting - verified September 2016
Conditions: End Stage Renal Disease (ESRD); Vascular Access Complication
Intervention: Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
Sponsor: Mayo Clinic
Not yet recruiting - verified June 2016
Intervention: Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
Sponsor: Mayo Clinic
Not yet recruiting - verified June 2016
Condition: Chronic Kidney Disease
Interventions: Drug: Group 2: Dasatinib; Drug: Group 2: Quercetin
Sponsor: Mayo Clinic
Recruiting - verified July 2016
Interventions: Drug: Group 2: Dasatinib; Drug: Group 2: Quercetin
Sponsor: Mayo Clinic
Recruiting - verified July 2016
Conditions: Glomerulosclerosis, Focal Segmental; Renal Insufficiency, Chronic
Intervention: Biological: Autologous Cell Transplantation
Sponsors: Universidade Federal do Rio de Janeiro; Ministry of Science and Technology, Brazil; Ministry of Health, Brazil; National Research Council, Brazil; Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Recruiting - verified February 2016
Intervention: Biological: Autologous Cell Transplantation
Sponsors: Universidade Federal do Rio de Janeiro; Ministry of Science and Technology, Brazil; Ministry of Health, Brazil; National Research Council, Brazil; Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Recruiting - verified February 2016
Condition: Acute Kidney Injury
Interventions: Drug: AST-120and pentoxyphylline (PTX); Drug: pentoxyphylline (PTX)
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital, Yun-Lin Branch; National Taiwan University Hospital Hsin-Chu Branch; China Medical University Hospital; Taoyuan General Hospital; Taipei Medical University Hospital; Chang Gung Memorial Hospital
Recruiting - verified February 2016
Interventions: Drug: AST-120and pentoxyphylline (PTX); Drug: pentoxyphylline (PTX)
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital, Yun-Lin Branch; National Taiwan University Hospital Hsin-Chu Branch; China Medical University Hospital; Taoyuan General Hospital; Taipei Medical University Hospital; Chang Gung Memorial Hospital
Recruiting - verified February 2016
Condition: Diabetic Kidney Disease
Interventions: Biological: Mesenchymal Stromal Cells; Other: Placebo
Sponsors: Mario Negri Institute for Pharmacological Research; Leiden University Medical Center; NHS Blood and Transplant; A.O. Ospedale Papa Giovanni XXIII; Istituto Di Ricerche Farmacologiche Mario Negri; Belfast Health and Social Care Trust; National University of Ireland, Galway, Ireland; University Hospital Birmingham
Not yet recruiting - verified October 2015
Interventions: Biological: Mesenchymal Stromal Cells; Other: Placebo
Sponsors: Mario Negri Institute for Pharmacological Research; Leiden University Medical Center; NHS Blood and Transplant; A.O. Ospedale Papa Giovanni XXIII; Istituto Di Ricerche Farmacologiche Mario Negri; Belfast Health and Social Care Trust; National University of Ireland, Galway, Ireland; University Hospital Birmingham
Not yet recruiting - verified October 2015
Condition: Urinary Incontinence by Intrinsic Sphincter Deficiency
Intervention: Other: Peri sphincter injection Autologous myofibers
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified October 2015
Intervention: Other: Peri sphincter injection Autologous myofibers
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified October 2015
Conditions: Kidney Transplantation; Acute Kidney Tubular Necrosis
Interventions: Other: BM-MSCs; Other: Saline
Sponsors: First Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University
Not yet recruiting - verified September 2015
Interventions: Other: BM-MSCs; Other: Saline
Sponsors: First Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University
Not yet recruiting - verified September 2015
Conditions: Kidney Transplantation; Acute Kidney Tubular Necrosis
Interventions: Other: bone marrow-derived mesenchymal stem cells; Other: Saline; Drug: Induction therapy (ATG or Basiliximab); Drug: Maintenance therapy (Low-dose CNI + MPA + steroids)
Sponsors: First Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University
Not yet recruiting - verified September 2015
Interventions: Other: bone marrow-derived mesenchymal stem cells; Other: Saline; Drug: Induction therapy (ATG or Basiliximab); Drug: Maintenance therapy (Low-dose CNI + MPA + steroids)
Sponsors: First Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University
Not yet recruiting - verified September 2015
2023 AlphaMed Press ©